KEY TAKEAWAYS
- OKX will list BIO Protocol (BIO) on its spot trading markets starting January 3, 2025.
- Trading for the BIO/USDT pair will begin at 10:15 am UTC, with specific restrictions to manage initial price volatility.
- BIO Protocol aims to enhance decentralized science by facilitating capital and talent flow into onchain science.
OKX has announced the listing of BIO Protocol (BIO) on its spot trading markets. The listing will commence on January 3, 2025, with a series of scheduled events to facilitate the introduction of the new asset.
The timeline for the listing includes the opening of BIO deposits at 5:30 am UTC, followed by a call auction from 9:15 am to 10:15 am UTC. Spot trading for the BIO/USDT pair will begin at 10:15 am UTC, and withdrawals will be available from 2:00 pm UTC on the same day.
Trading Rules and Mechanisms
To manage price volatility at the start of trading, OKX will implement specific restrictions. During the first five minutes of trading, market orders will not be allowed, and each limit order must not exceed a value of 10,000 USD. These restrictions will be lifted after the initial five-minute period.
Additionally, OKX will apply price limits if a spot index is available for the trading pair. The price limits will be adjusted based on market conditions, with specific parameters outlined for the initial ten minutes and subsequent trading periods.
Introduction to BIO Protocol
BIO Protocol serves as a financial layer for decentralized science (DeSci), aiming to enhance the flow of capital and talent into onchain science. This initiative seeks to create shared intellectual property ownership among its members.
The asset, identified by the ticker BIO, has a total supply of 3,320,000,000. Interested parties can view the BIO Protocol price and further details on the OKX website.
Explore More News:
Disclaimer: The views expressed in this article are those of the authors and do not necessarily reflect the official policy of CoinsHolder. Content, including that generated with the help of AI, is for informational purposes only and is not intended as legal, financial, or professional advice. Readers should do their research before taking any actions related to the company and carry full responsibility for their decisions.